Identification of FDA-Approved Drugs with Activity against Stationary Phase Bartonella henselae

Bartonella henselae can cause various infections in humans, ranging from benign and self-limiting diseases to severe and life-threatening diseases as well as persistent infections that are difficult to treat. To develop more effective treatments for persistent Bartonella infections, in this study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tingting, Feng, Jie, Xiao, Shuzhen, Shi, Wanliang, Sullivan, David, Zhang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628006/
https://www.ncbi.nlm.nih.gov/pubmed/31035691
http://dx.doi.org/10.3390/antibiotics8020050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628006/
https://www.ncbi.nlm.nih.gov/pubmed/31035691
http://dx.doi.org/10.3390/antibiotics8020050

Ejemplares similares